Gnanagurudasan Prakasam, M.D.
Investigator
Dr. Prakasam is a pediatric endocrinologist at Sutter Medical Center, Sacramento (SMCS) and a senior scientist at the Sutter Institute for Medical Research (SIMR). He is Director of Pediatric Endocrinology and Diabetes at the Children's Center at SMCS.
In addition to his clinical practice, for over 20 years Dr. Prakasam and his endocrine team have conducted research in type 1 and 2 diabetes (including pediatric diabetes), diabetes technologies, pediatric obesity, growth hormones, puberty disorders, pediatric endocrine bone disorders, thyroid disorders, the science of happiness, telemedicine and growth disorders.
Formerly President of the Northern California Chapter of the American Diabetes Association, Dr. Prakasam is a current board member of the Juvenile Diabetes Research Foundation in Sacramento.
Dr. Prakasam has presented at national and international conferences with published research in high-impact journals including Diabetes, Journal of the Endocrine Society, Journal of Clinical Endocrinology & Metabolism and the Journal of Investigative Medicine. Dr. Prakasam trained in pediatrics in India (where he received a Bachelor of Medicine, Bachelor of Surgery and DIP in children’s health), the U.K. (MRCP) and in the U.S., where he trained in pediatric endocrinology at NYU Langone Hospital, N.Y.
He is board certified in pediatrics and pediatric endocrinology, and he has a Masters in Health Administration (MHA) from the University of Southern California.
Research studies
- Research study
Growth Hormone Deficiency SkybriGHt
A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA (SkybriGHt)
- Research study
Growth Hormone Deficiency SkyPass
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin (SkyPASS)
Clinical trials
- Clinical trial
Congenital Adrenal Hyperplasia in Pediatrics CRN04894-13
A Phase 2/3 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Atumelnant Treatment in Pediatric Participants With Congenital Adrenal Hyperplasia Including a Long-Term Extension
Status: Coming Soon
- Clinical trial
Growth Hormone Deficiency (GHD) LUM-201-10 OraGrowth
A Multicenter, 12-Month, Randomized, Double Blind, Placebo-Controlled Phase 3 Efficacy and Safety Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Open to Enrollment
- Clinical trial
Idiopathic Short Stature 111-210
A Phase 2, Randomized, Controlled, Multicenter Study of Vosoritide in Children With Idiopathic Short Stature
Status: Closed to Enrollment
- Clinical trial
Idiopathic Short Stature ASND0047 HighLiGHts
A Pivotal, Parallel-Arm, Phase 3, Open-Label, Active-controlled, Global, Multicenter, Randomized Basket Trial Investigating the Efficacy and Safety of Once-weekly Lonapegsomatropin Compared to Daily Somatropin in Prepubertal Children and Adolescents With Growth Failure or Short Stature Due to Growth Hormone Sufficient Disorders - Turner Syndrome, SHOX Deficiency, Small for Gestational Age, and Idiopathic Short Stature
Status: Open to Enrollment
- Clinical trial
Prader-Willi Syndrome TEMPO
A Phase 3, Randomized, Double-Blind, Placebo-controlled, Efficacy and Safety Study of Pitolisant Followed by an Open-Label Extension in Patients with Prader-Willi Syndrome
Status: Open to Enrollment